Koninklijke Philips NV Cash Flow Conversion Efficiency
Koninklijke Philips NV cash flow conversion efficiency. Based on the latest financial reports, Koninklijke Philips NV (PHIA) has a cash flow conversion efficiency ratio of 0.031x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€327.00 Million ≈ $382.30 Million USD) by net assets (€10.58 Billion ≈ $12.37 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Koninklijke Philips NV (1991–2024)
Cash flow conversion efficiency of Koninklijke Philips NV from 1991 to 2024. This chart illustrates how Koninklijke Philips NV's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Koninklijke Philips NV (PHIA) stock price for real-time trading data and today's change.
Koninklijke Philips NV Cash Flow Conversion Ratio Explained
Koninklijke Philips NV cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Koninklijke Philips NV Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Koninklijke Philips NV ranked by their cash flow conversion efficiency. Also see Koninklijke Philips NV (PHIA) market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Dow Inc
NYSE:DOW
|
0.067x |
|
ANTA Sports Products Limited
F:AS7
|
0.073x |
|
Swiss Life Holding AG
SW:SLHN
|
0.094x |
|
InterContinental Hotels Group PLC
LSE:IHG
|
-0.215x |
|
Equity Residential
NYSE:EQR
|
0.028x |
|
WUS Printed Circuit Kunshan Co Ltd
SHE:002463
|
0.059x |
|
HEXAGON AB ADR/1
F:HXGC
|
0.071x |
|
Telefónica S.A
MX:TEFN
|
0.138x |
Annual Cash Flow Conversion Efficiency for Koninklijke Philips NV (1991–2024)
The table below shows the annual cash flow conversion efficiency of Koninklijke Philips NV from 1991 to 2024. Review Koninklijke Philips NV (PHIA) free cash flow to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | €12.04 Billion ≈ $14.08 Billion |
€1.57 Billion ≈ $1.83 Billion |
0.130x | -26.44% |
| 2023-12-31 | €12.06 Billion ≈ $14.10 Billion |
€2.14 Billion ≈ $2.50 Billion |
0.177x | +1459.78% |
| 2022-12-31 | €13.28 Billion ≈ $15.53 Billion |
€-173.00 Million ≈ $-202.26 Million |
-0.013x | -111.57% |
| 2021-12-31 | €14.47 Billion ≈ $16.92 Billion |
€1.63 Billion ≈ $1.90 Billion |
0.113x | -51.77% |
| 2020-12-31 | €11.90 Billion ≈ $13.91 Billion |
€2.78 Billion ≈ $3.25 Billion |
0.233x | +45.05% |
| 2019-12-31 | €12.62 Billion ≈ $14.76 Billion |
€2.03 Billion ≈ $2.37 Billion |
0.161x | +9.51% |
| 2018-12-31 | €12.12 Billion ≈ $14.17 Billion |
€1.78 Billion ≈ $2.08 Billion |
0.147x | -5.55% |
| 2017-12-31 | €12.02 Billion ≈ $14.06 Billion |
€1.87 Billion ≈ $2.19 Billion |
0.156x | +10.35% |
| 2016-12-31 | €13.51 Billion ≈ $15.79 Billion |
€1.90 Billion ≈ $2.23 Billion |
0.141x | +42.28% |
| 2015-12-31 | €11.78 Billion ≈ $13.77 Billion |
€1.17 Billion ≈ $1.36 Billion |
0.099x | -16.61% |
| 2014-12-31 | €10.97 Billion ≈ $12.82 Billion |
€1.30 Billion ≈ $1.52 Billion |
0.119x | +17.20% |
| 2013-12-31 | €11.23 Billion ≈ $13.13 Billion |
€1.14 Billion ≈ $1.33 Billion |
0.101x | -48.47% |
| 2012-12-31 | €11.17 Billion ≈ $13.06 Billion |
€2.20 Billion ≈ $2.57 Billion |
0.197x | +330.57% |
| 2011-12-31 | €12.39 Billion ≈ $14.48 Billion |
€566.00 Million ≈ $661.71 Million |
0.046x | -68.02% |
| 2010-12-31 | €15.09 Billion ≈ $17.64 Billion |
€2.16 Billion ≈ $2.52 Billion |
0.143x | +35.40% |
| 2009-12-31 | €14.64 Billion ≈ $17.12 Billion |
€1.54 Billion ≈ $1.81 Billion |
0.106x | +10.04% |
| 2008-12-31 | €15.59 Billion ≈ $18.23 Billion |
€1.50 Billion ≈ $1.75 Billion |
0.096x | +52.47% |
| 2007-12-31 | €21.76 Billion ≈ $25.44 Billion |
€1.37 Billion ≈ $1.60 Billion |
0.063x | +70.31% |
| 2006-12-31 | €23.13 Billion ≈ $27.04 Billion |
€853.92 Million ≈ $998.32 Million |
0.037x | -69.98% |
| 2005-12-31 | €16.98 Billion ≈ $19.86 Billion |
€2.09 Billion ≈ $2.44 Billion |
0.123x | -30.95% |
| 2004-12-31 | €15.13 Billion ≈ $17.69 Billion |
€2.69 Billion ≈ $3.15 Billion |
0.178x | +15.69% |
| 2003-12-31 | €12.92 Billion ≈ $15.10 Billion |
€1.99 Billion ≈ $2.32 Billion |
0.154x | -2.59% |
| 2002-12-31 | €14.11 Billion ≈ $16.50 Billion |
€2.23 Billion ≈ $2.61 Billion |
0.158x | +136.30% |
| 2001-12-31 | €18.69 Billion ≈ $21.85 Billion |
€1.25 Billion ≈ $1.46 Billion |
0.067x | -50.44% |
| 2000-12-31 | €22.27 Billion ≈ $26.03 Billion |
€3.00 Billion ≈ $3.51 Billion |
0.135x | +6.42% |
| 1999-12-31 | €15.13 Billion ≈ $17.69 Billion |
€1.92 Billion ≈ $2.24 Billion |
0.127x | -17.93% |
| 1998-12-31 | €14.36 Billion ≈ $16.79 Billion |
€2.22 Billion ≈ $2.59 Billion |
0.154x | -56.25% |
| 1997-12-31 | €9.81 Billion ≈ $11.47 Billion |
€3.46 Billion ≈ $4.05 Billion |
0.353x | +107.03% |
| 1996-12-31 | €7.14 Billion ≈ $8.34 Billion |
€1.22 Billion ≈ $1.42 Billion |
0.171x | -4.18% |
| 1995-12-31 | €6.82 Billion ≈ $7.98 Billion |
€1.21 Billion ≈ $1.42 Billion |
0.178x | -48.90% |
| 1994-12-31 | €6.78 Billion ≈ $7.93 Billion |
€2.36 Billion ≈ $2.76 Billion |
0.348x | -20.66% |
| 1993-12-31 | €6.03 Billion ≈ $7.04 Billion |
€2.65 Billion ≈ $3.09 Billion |
0.439x | +9.69% |
| 1992-12-31 | €4.13 Billion ≈ $4.82 Billion |
€1.65 Billion ≈ $1.93 Billion |
0.400x | +55.04% |
| 1991-12-31 | €5.79 Billion ≈ $6.77 Billion |
€1.49 Billion ≈ $1.75 Billion |
0.258x | -- |
About Koninklijke Philips NV
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment, Connected Care, and Personal Health segments. It provides diagnostic imaging solutions, includes magnetic resonance imaging; X-ray systems; and computed tomography (CT) systems and software comprising detector-based spectral… Read more